Clinical Trial Update: Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

View source ↗

Summary

A clinical trial update describing an epidemiological study to determine how common EGFR mutation status is in patients newly diagnosed with locally advanced or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED